IQVIA Holdings | IQV - Sales Revenues


IQVIA Holdings reported $4.15B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Accenture USD 18.7B 700M Mar/2026
Agilent USD 1.84B 37M Mar/2026
Bruker USD 823.4M 153.8M Mar/2026
Cardinal Health USD 60.9B 4.73B Mar/2026
Celltrion KRW 1.24T 90B Jun/2026
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Cigna USD 68.52B 3.95B Mar/2026
Cognizant Technology Solutions USD 5.41B 110M Mar/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
CVS Health USD 100.4B 5.3B Mar/2026
Danaher USD 6.3B 350M Jun/2026
Dentsply International USD 880M 81M Mar/2026
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 463K 179K Mar/2026
Divis Laboratories Ltd INR 28.31B 2.27B Mar/2026
Elevance Health USD 49.8B 300M Jun/2026
Humana USD 39.65B 7.13B Mar/2026
IBM USD 17.2B 1.28B Jun/2026
Illumina USD 1.09B 70M Mar/2026
Infosys INR 474.3B 19.51B Mar/2026
Kangmei Pharma CNY 1.08B 288.27M Mar/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Laboratory Of America USD 3.54B 20M Mar/2026
McKesson USD 92.3B 13.86B Mar/2026
Mettler Toledo International USD 947.13M 182.87M Mar/2026
Organigram Holdings CAD 59.79M 3.74M Mar/2026
Pharma Mar EUR 42.9M 47.3M Mar/2026
Publicis EUR 3.77B 310M Jun/2026
Qiagen NV USD 419.22M 38.16M Mar/2026
Quest Diagnostics USD 2.9B 90M Mar/2026
Revvity USD 711M 61.06M Mar/2026
Sartorius EUR 899.1M 28.5M Mar/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Tilray USD 217.51M 74.75M Dec/2025
UnitedHealth USD 112B 300M Jun/2026
Veeva Systems USD 882.95M 47M Mar/2026
Veradigm USD 142.52M 9.38M Dec/2022
Waters USD 1.27B 338M Mar/2026
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026